ClariMed Inc. Acquires We Are Human, Expanding Growth into Southeast Market
CHADDS FORD, Pa., Aug. 12, 2025 /CNW/ — ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced the strategic acquisition of We Are Human, a UK and US-based consultancy specializing in user-focused design and research in MedTech innovation. The acquisition expands ClariMed's geographic reach into the Southeast through We Are Human's state-of-the-art Atlanta research facility while advancing the company's mission to enable innovative, human-centered medical technologies and make them accessible to communities that need them.
Annmarie Nicolson, founder of We Are Human, will join ClariMed as Principal, bringing her extensive experience in early-stage formative research, contextual inquiry, and UX research for MedTech innovation to the leadership team. The acquisition brings the complete We Are Human team and their Atlanta research facility into the ClariMed family, expanding the company's presence in the Southeast region.
'This acquisition represents our continued commitment to our user-centered foundation while expanding our reach and strengthening our capabilities,' said Kelley Kendle, CEO of ClariMed. 'Regional variability allows us to better address our patients' needs and advance our mission to make medical technology safer, more intuitive, and more impactful for the people who need it most. This isn't just a merger of capabilities — it's a deep alignment of values.'
The acquisition strengthens ClariMed's position as an integrated medical device services partner, expanding specialized expertise in user experience research, regulatory compliance, and design validation across both US and UK markets. We Are Human brings ISO 13485 certification and extensive experience with IEC-62366 and FDA Guidance requirements, having conducted research with hundreds of healthcare professionals, lay persons and diverse patient groups. The Atlanta laboratory will serve as ClariMed's newest research facility, offering access to diverse study populations in the Southeast while supporting the company's growing client base.
'Joining ClariMed represents an exciting opportunity to amplify our impact in healthcare through human-centered research and design,' said Annmarie. 'Both organizations have a long-standing commitment to putting users first and creating products that truly make a difference in people's lives. This shared dedication to excellence and user-centered principles positions us to deliver even more meaningful solutions- both to our clients and, to the patients and healthcare providers who rely on innovative medical technology every day.'
The integration of We Are Human establishes ClariMed's first Southeast location, joining strategic offices across the United States and internationally, including Chadds Ford, PA; Cambridge, MA; San Jose, CA; Cambridge, UK; Leeds, UK; and now Atlanta, GA. This expanded geographic network enhances ClariMed's ability to serve global clients while accessing diverse talent pools and participant populations for user research and usability testing.
This acquisition aligns with ClariMed's growth strategy of building comprehensive, human-centered solutions for medical device development. The combined expertise of both organizations positions ClariMed to better serve pharmaceutical and medical device manufacturers seeking to accelerate time to market while enhancing patient safety and user experience.
About ClariMed
ClariMed is a human-centered development and regulatory practice for medical products developed by pharmaceutical and medical device manufacturers. Our best-of-breed professional services cultivate innovation while ensuring the safe and effective use of medical products. With offices across the United States and United Kingdom, ClariMed delivers comprehensive solutions that integrate human factors at the core of device development and regulatory pathways. Visit us at www.clarimed.com.
About We Are Human
Founded in 2020, We Are Human is an ISO 13485 certified consultancy, based in the UK and US specializing in Human Factors, User Research and UX, with deep expertise in human-centered research and design for healthcare. The company was founded on the belief that human needs should be at the heart of design, striving to improve quality of life, health, and wellbeing through product development. We Are Human brings extensive experience in Human Factors and Usability Engineering standards and regulatory requirements for medical device development, including IEC-62366 and FDA Guidance, with a track record of collaborating with clients across Medical Devices, Combination Products, FemTech, Digital Health and over-the-counter (OTC) products.
For media inquiries, please contact: press@clarimed.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
9 minutes ago
- The Star
China, India in talks to resume border trade after 5-year pause
FILE PHOTO: A worker rolls up carpets at an export house in Noida, India, on Tuesday, Aug. 25, 2009. For over three decades, India and China had traded locally produced goods - such as spices, carpets, wooden furniture, cattle fodder, pottery, medicinal plants, electric items, and wool - through three designated points along their 3,488-kilometre disputed Himalayan border. - Bloomberg NEW DELHI: India and China are discussing resuming border trade of locally made goods after more than five years, marking the latest step in a slow but steady effort by the Asian neighbours to ease long-standing tensions, according to officials in New Delhi familiar with the matter. Both sides have proposed restarting trade through designated points on the shared border, and the matter is currently under bilateral discussion, the people said, asking not to be identified as the discussions are still private. China's Ministry of Foreign Affairs said Thursday (Aug 14) that Beijing is "willing to step up communication and coordination with India' on the matter. "Border trade between China and India has long played an important role in improving lives of the two countries' border residents,' it said in a response to a query from Bloomberg News. India's Ministry of External Affairs didn't respond to an email seeking further information. For over three decades, India and China had traded locally produced goods - such as spices, carpets, wooden furniture, cattle fodder, pottery, medicinal plants, electric items, and wool - through three designated points along their 3,488-kilometre disputed Himalayan border. The trade value is relatively small, estimated at just US$3.16 million in 2017-18, according to the most recent government data available. The trading points were shut during the Covid-19 pandemic, which coincided with a sharp decline in relations between the two nations after border clashes in the Himalayas killed 20 Indian soldiers and at least four Chinese troops. The planned resumption marks another sign that relations between the two neighbours are gradually improving after both sides took steps last year to end border tensions. China and India are set to resume direct flight connections as soon as next month, Bloomberg News reported Tuesday, while Beijing has eased curbs on some fertilizer shipments to India. Prime Minister Narendra Modi is expected to head to China for the first time in seven years in August to attend a summit of the Beijing-led regional security grouping - the Shanghai Cooperation Organisation - and hold a bilateral meeting with President Xi Jinping on the sidelines. The normalising in ties between the two countries come against the backdrop of deteriorating relations between New Delhi and US President Donald Trump, who has imposed a 50 per cent tariff rate on Indian exports to the US, significantly higher than the duties imposed on regional peers. - Bloomberg
New Straits Times
9 minutes ago
- New Straits Times
South Korea to announce plan to restructure petrochemical sector facing 'grave' situation
SEOUL/NEW DELHI: South Korea's government will announce a plan this month to restructure the country's petrochemical sector, which is in a "grave" situation, Industry Minister Kim Jung-kwan said on Thursday. South Korean petrochemical companies must take lessons from the restructuring of the country's shipbuilding industry in the late 2010s, when shipmakers had to liquidate assets and streamline business areas amid a sharp drop in orders, Kim said. Margins have plunged for petrochemical companies in South Korea and across the globe due to an oversupply of products caused by relentless capacity additions in the last decade, particularly in China, the biggest petrochemical market. Demand has also been sluggish over the last three to four years. "A restructuring in the petrochem industry has been highly expected, given the industry is running merely 80 per cent of total capacity in Korea now - meaning we have about a 20 per cent glut here," said Hwang Kyu-won, an analyst at Yuanta Securities Korea. Kim, who was speaking at a shipyard, said the petrochemical industry needed to take voluntary measures, including the "adjustment" of facilities, his ministry quoted him as saying. There have been concerns as well over the financial health of South Korea's loss-making Yeochun NCC Co (YNCC), a Yeosu-based petrochemical maker that local media says faces 180 billion won (US$130 million) in loans coming due at the end of August. South Korea's government can use YNCC's travails as an opportunity for a large-scale restructuring in the industry, said the analyst Hwang. Analysts say the industry does not expect global petrochemical margins to recover before 2027. The last major restructuring for South Korea's petrochemical industry was in 1999 during the Asian Financial Crisis, when YNCC was formed. President Lee Jae Myung, who took office after a snap election in June, pledged during his campaign to pursue tax support for mergers and acquisitions in the petrochemical industry, and to exempt companies from antitrust regulations to allow more coordination of production and operations. South Korea's exports of petrochemical products stood at US$21.7 billion in the first half of this year, down 11.1 per cent from a year earlier, amid price declines and global oversupply. Total exports of petrochemical products were US$48 billion in 2024, accounting for 7 per cent of South Korea's total exports and a top-five export item after semiconductors, automobiles, machinery and petroleum products. South Korea is one of the world's largest importers of naphtha, a derivative of crude oil that is refined into chemical products used in plastics for automobiles, electronics, clothing and construction. If the country is forced to cut capacity, it could impact global oil markets. Other South Korean petrochemical companies besides YNCC are also seeing asset reshuffling. HD Hyundai is looking to acquire Lotte Chemical's naphtha cracker, or the companies may merge their cracker operations, trade sources have said. HD Hyundai said nothing has been decided yet.
New Straits Times
39 minutes ago
- New Straits Times
Premier League champions Liverpool go all out in transfer spree
LIVERPOOL: Fresh from storming to a record-equalling 19th English top-flight title, Liverpool have not held back in transforming Arne Slot's squad in pursuit of an era of Premier League dominance. On top of retaining veteran stars Virgil van Dijk and Mohamed Salah to new contracts, the Reds have splashed out £260 million (US$350 million) and are reportedly far from finished in the transfer market. Two of the Bundesliga's most promising talents Florian Wirtz and Hugo Ekitike have arrived at Anfield to add extra creativity and goals. Jeremie Frimpong has also made the move from Germany with the daunting task of replacing Trent Alexander-Arnold at right-back, while Milos Kerkez joined from Bournemouth as the long-term successor to Andy Robertson at left-back. More defensive reinforcements are imminent with the club closing in on deals for Crystal Palace captain Marc Guehi and 18-year-old Italian centre-back Giovanni Leoni from Parma. But it is the potential addition of Newcastle striker Alexander Isak for a British transfer record fee in excess of £115 million that is the transfer saga of the English summer. Liverpool were among the lowest Premier League spenders last year as Slot oversaw a steady transition from Jurgen Klopp in spectacular style. A huge investment this time round is also possible because the Reds are among the slickest movers in the market when it comes to sales. The departures of Luis Diaz, Darwin Nunez, Jarell Quansah, Caoimhin Kelleher, Alexander-Arnold and Tyler Morton have raised around £200 million. Liverpool's bold strategy of tearing up a title-winning team is a risky and rare experiment. Only once, Manchester City in 2019, have the Premier League champions been the biggest spending English club in the market since 2007. After years of battling against the financial power of Abu Dhabi-backed City, Liverpool are now flexing their muscles thanks to years of commercial growth and prudent ownership. "It doesn't feel Liverpool-like to me," said former defender Jamie Carragher at the thought of a new £69 million striker Ekitike playing second fiddle to Isak. After decades in the doldrums prior to Klopp's arrival, Liverpool are aiming to bring back glory days the club has not since the 1980s. The last time Liverpool won back-to-back titles was in 1984 and doing so this season would come with the added bonus of overtaking Manchester United as English football's top dogs. To do so, Slot has recognised the need to strike the right balance that still harnesses the best from his side's extra firepower. A pre-season trend of high-scoring encounters continued in losing the Community Shield to Crystal Palace on penalties after twice blowing the lead. "Now we are better in creating and getting promising situations than we were, in my opinion, throughout the whole of last season," said Slot. "What made us really strong last season was we only won mostly by a margin of one goal and that had mostly to do with us keeping a clean sheet or as a maximum conceding one goal." Liverpool also have extra motivation to defend their title as they try to honour a lost friend and team-mate in Diogo Jota. The Portuguese international was killed aged just 28 alongside his brother after a car accident in northern Spain last month. Tributes to Jota will continue throughout the season with "Forever 20" – his shirt number, which the club have now retired – printed on Liverpool's jerseys.--AFP
